Washington Trust’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Washington Trust’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50	Closed	-$5K	–	1002
2021 Q4	$5K	Hold	50	–	–	﹤0.01%	752
2021 Q3	$3K	Hold	50	–	–	﹤0.01%	933
2021 Q2	$3K	Hold	50	–	–	﹤0.01%	921
2021 Q1	$3K	Hold	50	–	–	﹤0.01%	885
2020 Q4	$4K	Hold	50	–	–	﹤0.01%	826
2020 Q3	$4K	Hold	50	–	–	﹤0.01%	830
2020 Q2	$3K	Hold	50	–	–	﹤0.01%	755
2020 Q1	$2K	Buy	+50	New	+$2.29K	﹤0.01%	866
2018 Q3	–	Sell	-50	Closed	-$2K	–	894
2018 Q2	$2K	Buy	+50	New	+$2.15K	﹤0.01%	835

Washington Trust's ARNA Position: Q1 2022 in Review

Washington Trust sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 50 shares — an estimated $5K sold.

Washington Trust first reported a position in ARNA in Q2 2018 and held it in 9 quarters. The position peaked at $5K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Washington Trust reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Washington Trust sold 50 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5K.
Washington Trust first reported a position in Arena Pharmaceuticals Inc in Q2 2018 and held it in 9 quarters.
Washington Trust's Arena Pharmaceuticals Inc position peaked at $5K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Washington Trust's 13F filing for Q1 2022, filed 5 May 2022.